Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes January 12, 2023 Press Releases
Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes January 4, 2023 Press Releases
Oramed Announces Publication of Oral Insulin Study in Peer-Reviewed Journal: Diabetes, Obesity, and Metabolism November 29, 2022 Press Releases
Oramed Announces Additional Positive Safety and Efficacy Data from Its Phase 2 Clinical Trial of ORMD-0801 for NASH November 17, 2022 Press Releases
Oramed Signs Definitive Deal with Medicox to Commercialize Oral Insulin in South Korea November 14, 2022 Press Releases
